Rumiàa, J., Marmolb, F., Sanchezb, J., Giménez-Crouseillesc, J., Carrenod, M., Bargallód, N., Bogetd, T., Pintord, L., Setoaind, X., Donaired, A., Saeze, G.T., Ribaltaf, T., Ferrera, E. and Puig-Parelladaba, P. (2013) Oxidative Stress Markers in the Neocortex of Drug-Resistant Epilepsy Patient Submitted to Epilepsy Surgery. Epilepsy Research, 107, 75- 81.
http://dx.doi.org/10.1016/j.eplepsyres.2013.08.020

has been cited by the following article:

• TITLE: Experience of Using the Recombinant Human Superoxide Dismutase Drug in Neurological and Ophthalmological Practice

  AUTHORS: Elena E. Dubinina, Irina V. Churilova, Liudmila V. Lipatova, Liudmila V. Zhuravleva

  KEYWORDS: Superoxide Dismutase, Oxidative Stress, Reactive Oxygen Species, Epilepsy, Age-Related Macular Degeneration

  JOURNAL NAME: Open Journal of Medicinal Chemistry, Vol.4 No.2, June 23, 2014

  ABSTRACT: Recsod? has been used for treating epilepsy and ophthalmological disease. Oxidative stress has been demonstrated to be a pathogenic chain of these diseases. Parameters of pro- and antioxidant systems were studied in all the patients treated. Recsod? drug was shown to produce positive effect in all the patients. Improvement of patients’ clinical condition correlated with an increase in antioxidant activities. Antioxidants, in particular, the recombinant human SOD drug, proved to be effective in treatment of some neurological and ophthalmological diseases.